BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30529449)

  • 1. Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma.
    Brinkman P; Wagener AH; Hekking PP; Bansal AT; Maitland-van der Zee AH; Wang Y; Weda H; Knobel HH; Vink TJ; Rattray NJ; D'Amico A; Pennazza G; Santonico M; Lefaudeux D; De Meulder B; Auffray C; Bakke PS; Caruso M; Chanez P; Chung KF; Corfield J; Dahlén SE; Djukanovic R; Geiser T; Horvath I; Krug N; Musial J; Sun K; Riley JH; Shaw DE; Sandström T; Sousa AR; Montuschi P; Fowler SJ; Sterk PJ;
    J Allergy Clin Immunol; 2019 May; 143(5):1811-1820.e7. PubMed ID: 30529449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    de Vries R; Dagelet YWF; Spoor P; Snoey E; Jak PMC; Brinkman P; Dijkers E; Bootsma SK; Elskamp F; de Jongh FHC; Haarman EG; In 't Veen JCCM; Maitland-van der Zee AH; Sterk PJ
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; de Vries R; Dagelet YWF; Riley JH; Hashimoto S; Montuschi P; Chung KF; Djukanovic R; Fleming LJ; Murray CS; Frey U; Bush A; Singer F; Hedlin G; Roberts G; Dahlén SE; Adcock IM; Fowler SJ; Knipping K; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH; ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1045-1055. PubMed ID: 32531371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; Riley JH; Bates S; Hashimoto S; Kermani NZ; Chung KF; Djukanovic R; Dahlén SE; Adcock IM; Howarth PH; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):123-134. PubMed ID: 32353491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human volatilome analysis using eNose to assess uncontrolled asthma in a clinical setting.
    Farraia M; Cavaleiro Rufo J; Paciência I; Castro Mendes F; Rodolfo A; Rama T; Rocha SM; Delgado L; Brinkman P; Moreira A
    Allergy; 2020 Jul; 75(7):1630-1639. PubMed ID: 31997360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions.
    Fens N; van der Schee MP; Brinkman P; Sterk PJ
    Clin Exp Allergy; 2013 Jul; 43(7):705-15. PubMed ID: 23786277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased day-to-day fluctuations in exhaled breath profiles after a rhinovirus challenge in asthma.
    Lammers A; Brinkman P; Te Nijenhuis LH; de Vries R; Dagelet YWF; Duijvelaar E; Xu B; Abdel-Aziz MI; Vijverberg SJ; Neerincx AH; Frey U; Lutter R; Maitland-van der Zee AH; Sterk PJ; Sinha A
    Allergy; 2021 Aug; 76(8):2488-2499. PubMed ID: 33704785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis.
    Moore WC; Hastie AT; Li X; Li H; Busse WW; Jarjour NN; Wenzel SE; Peters SP; Meyers DA; Bleecker ER;
    J Allergy Clin Immunol; 2014 Jun; 133(6):1557-63.e5. PubMed ID: 24332216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
    Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.
    Schleich FN; Zanella D; Stefanuto PH; Bessonov K; Smolinska A; Dallinga JW; Henket M; Paulus V; Guissard F; Graff S; Moermans C; Wouters EFM; Van Steen K; van Schooten FJ; Focant JF; Louis R
    Am J Respir Crit Care Med; 2019 Aug; 200(4):444-453. PubMed ID: 30973757
    [No Abstract]   [Full Text] [Related]  

  • 18. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
    Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
    Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotyping of difficult asthma using longitudinal physiological and biomarker measurements reveals significant differences in stability between clusters.
    Zaihra T; Walsh CJ; Ahmed S; Fugère C; Hamid QA; Olivenstein R; Martin JG; Benedetti A
    BMC Pulm Med; 2016 May; 16(1):74. PubMed ID: 27165150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.